Concepedia
Statistics
Publications
1
Citations
25
H-Index
Active since
2021
Affiliations
The University of Texas Southwestern Medical Center(Current)
Shreeju Shrestha is an author at The University of Texas Southwestern Medical Center.
Publications per year
2021–2021
Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease
Ernesto M. Llano, Shreeju Shrestha, Ezra Burstein et al. · Crohn s & Colitis 360 · 2021 · 25 citations · Full text
1–1 of 1